Documents
Application Sponsors
ANDA 208786 | MYLAN LABS LTD | |
Marketing Status
Application Products
001 | SOLUTION;INTRAVENOUS | 37.5MG/ML (37.5MG/ML) | 0 | DICLOFENAC SODIUM | DICLOFENAC SODIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-06-18 | STANDARD |
Submissions Property Types
CDER Filings
MYLAN LABS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 208786
[companyName] => MYLAN LABS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"DICLOFENAC SODIUM","activeIngredients":"DICLOFENAC SODIUM","strength":"37.5MG\/ML (37.5MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/18\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/208786Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-06-18
)
)